| Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard J Clin Oncol 27 (12), 1992-1998, 2009 | 750 | 2009 |
| Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind … J Overgaard, JG Eriksen, M Nordsmark, J Alsner, MR Horsman The lancet oncology 6 (10), 757-764, 2005 | 306 | 2005 |
| HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard Radiotherapy and Oncology 94 (1), 30-35, 2010 | 232 | 2010 |
| The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial P Lassen, JG Eriksen, A Krogdahl, MH Therkildsen, BP Ulhøi, ... Radiotherapy and Oncology 100 (1), 49-55, 2011 | 207 | 2011 |
| Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey C Grau, N Defourny, J Malicki, P Dunscombe, JM Borras, M Coffey, ... Radiotherapy and Oncology 112 (2), 155-164, 2014 | 201 | 2014 |
| Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer P Lassen, H Primdahl, J Johansen, CA Kristensen, E Andersen, ... Radiotherapy and Oncology 113 (3), 310-316, 2014 | 188 | 2014 |
| Automatic planning of head and neck treatment plans I Hazell, K Bzdusek, P Kumar, CR Hansen, A Bertelsen, JG Eriksen, ... Journal of applied clinical medical physics 17 (1), 272-282, 2016 | 162 | 2016 |
| The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the … JG Eriksen, T Steiniche, J Askaa, J Alsner, J Overgaard International Journal of Radiation Oncology* Biology* Physics 58 (2), 561-566, 2004 | 148 | 2004 |
| Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation AB Oturai, K Jensen, J Eriksen, F Madsen The Clinical journal of pain 12 (4), 311-315, 1996 | 147 | 1996 |
| Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations S Aarup-Kristensen, CR Hansen, L Forner, C Brink, JG Eriksen, ... Acta Oncologica 58 (10), 1373-1377, 2019 | 140 | 2019 |
| Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey Y Lievens, N Defourny, M Coffey, JM Borras, P Dunscombe, B Slotman, ... Radiotherapy and oncology 112 (2), 178-186, 2014 | 127 | 2014 |
| Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000 SA Theilgaard, C Buchwald, P Ingeholm, SK Larsen, JG Eriksen, ... Acta oto-laryngologica 123 (3), 433-439, 2003 | 125 | 2003 |
| Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans CR Hansen, A Bertelsen, I Hazell, R Zukauskaite, N Gyldenkerne, ... Clinical and translational radiation oncology 1, 2-8, 2016 | 115 | 2016 |
| European white paper: oropharyngeal dysphagia in head and neck cancer LWJ Baijens, M Walshe, LM Aaltonen, C Arens, R Cordier, P Cras, ... European Archives of Oto-Rhino-Laryngology 278, 577-616, 2021 | 113 | 2021 |
| Esthesioneuroblastoma: what is the optimal treatment? JG Eriksen, Lars Bastholt, Annelise S. Krogdahl, Olfred Hansen, Karsten E ... Acta oncologica 39 (2), 231-235, 2000 | 105 | 2000 |
| Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients M Nordsmark, JG Eriksen, V Gebski, J Alsner, MR Horsman, J Overgaard Radiotherapy and oncology 83 (3), 389-397, 2007 | 103 | 2007 |
| Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study J Bentzen, K Toustrup, JG Eriksen, H Primdahl, LJ Andersen, J Overgaard Acta oncologica 54 (7), 1001-1007, 2015 | 102 | 2015 |
| The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the … JG Eriksen, T Steiniche, J Overgaard Radiotherapy and oncology 74 (2), 93-100, 2005 | 101 | 2005 |
| The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology JG Eriksen, AW Beavis, MA Coffey, JWH Leer, SM Magrini, K Benstead, ... Radiotherapy and Oncology 103 (1), 103-108, 2012 | 95 | 2012 |
| Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey P Dunscombe, C Grau, N Defourny, J Malicki, JM Borras, M Coffey, ... Radiotherapy and Oncology 112 (2), 165-177, 2014 | 90 | 2014 |
